DRKS00011651
Completed
未知
Test-retest reliability of quantitative MRI parameters in a prospective single-center neurooncological imaging study
Abt. Neuroradiologie - Universitätsklinikum Heidelberg0 sites60 target enrollmentJanuary 27, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Intra-session test-retest reliability of quantitative MRI parameters in neurooncological MRI imaging of the brain
- Sponsor
- Abt. Neuroradiologie - Universitätsklinikum Heidelberg
- Enrollment
- 60
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-capacity to consent to treatment as defined under German law
- •\-supratentorial intraaxial or mainly supratentorial intraaxial tumor that has been histologically proven
- •\-supratentorial contrast enhancement \= 3 x 3 x 3 mm
- •\-appointment for routine follow\-up MRI of the brain
- •\-isovolumetric contrast\-enhanced and isovolumetirc T1w volume in routine follow\-up MRI imaging
Exclusion Criteria
- •\-pregnancy
- •\-inflammatory CNS disease
- •\-pronounced motion artefacts
- •\-adipositas per magna
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Test-retest validation of quantitative MRIcancermalignancy10027655NL-OMON50975Antoni van Leeuwenhoek Ziekenhuis208
Recruiting
Not Applicable
Test-retest validation of quantitative MRI in healthy volunteersNL-OMON49913Antoni van Leeuwenhoek Ziekenhuis200
Recruiting
Not Applicable
sefulness of quantitative MRI in the evaluation of pancreatic fibrosis and evaluation of residual pancreatic exocrine functiopancreatic tumorJPRN-UMIN000050347Kawasaki Medical School40
Completed
Not Applicable
Test-retest reliability on ePOD fMRI studieshet onderzoek betreft geen aandoeningTest-retest effect on fMRINL-OMON36088Academisch Medisch Centrum
Active, not recruiting
Not Applicable
To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancyEUCTR2004-002053-31-GBHammersmith Hospital100